High Tower Advisors, LLC Pro Phase Labs, Inc. Transaction History
High Tower Advisors, LLC
- $64.2 Billion
- Q2 2024
A detailed history of High Tower Advisors, LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 151,372 shares of PRPH stock, worth $343,614. This represents 0.0% of its overall portfolio holdings.
Number of Shares
151,372
Previous 153,649
1.48%
Holding current value
$343,614
Previous $994,000
36.42%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PRPH
# of Institutions
30Shares Held
1.67MCall Options Held
500Put Options Held
6K-
Vanguard Group Inc Valley Forge, PA656KShares$1.49 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny221KShares$500,5570.0% of portfolio
-
Geode Capital Management, LLC Boston, MA147KShares$334,0190.0% of portfolio
-
Perritt Capital Management Inc Chicago, IL85.5KShares$194,0850.21% of portfolio
-
Black Rock Inc. New York, NY64.3KShares$145,9580.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $36.4M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...